• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug approval

Novo Nordisk Wegovy Wegovy Wegovy HD semaglutide Wegovy 72 mg
Pharma

Novo scores FDA nod for Wegovy HD, plans April launch

Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 Wegovy in an increasingly pressured obesity market.
Fraiser Kansteiner Mar 19, 2026 2:11pm
GLP-1 diabetes obesity Ozempic Wegovy Novo Lilly Zepbound Mounjaro

Pfizer snaps up rights to commercialize diabetes GLP-1 in China

Feb 24, 2026 11:15am
China flag

China approves 4 new drugs, including global 1st-in-class

Jul 2, 2025 11:32am
mazdutide Innovent

Lilly, Innovent's mazdutide nabs first-in-class nod in China

Jun 27, 2025 11:16am
Europe European Union EU European Commission EC

EU authorities revoke marketing nod for Advanz Pharma's Ocaliva

Dec 2, 2024 2:54pm
OHTUVAYRE

Verona earns FDA nod for potential blockbuster to treat COPD

Jun 26, 2024 6:26pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings